112 related articles for article (PubMed ID: 15357987)
1. Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxol-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamides.
Wu YJ; Sun LQ; He H; Chen J; Starrett JE; Dextraze P; Daris JP; Boissard CG; Pieschl RL; Gribkoff VK; Natale J; Knox RJ; Harden DG; Thompson MW; Fitzpatrick W; Weaver D; Wu D; Gao Q; Dworetzky SI
Bioorg Med Chem Lett; 2004 Sep; 14(17):4533-7. PubMed ID: 15357987
[TBL] [Abstract][Full Text] [Related]
2. (S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neurons.
Wu YJ; Boissard CG; Chen J; Fitzpatrick W; Gao Q; Gribkoff VK; Harden DG; He H; Knox RJ; Natale J; Pieschl RL; Starrett JE; Sun LQ; Thompson M; Weaver D; Wu D; Dworetzky SI
Bioorg Med Chem Lett; 2004 Apr; 14(8):1991-5. PubMed ID: 15050644
[TBL] [Abstract][Full Text] [Related]
3. (S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activity.
L'Heureux A; Martel A; He H; Chen J; Sun LQ; Starrett JE; Natale J; Dworetzky SI; Knox RJ; Harden DG; Weaver D; Thompson MW; Wu YJ
Bioorg Med Chem Lett; 2005 Jan; 15(2):363-6. PubMed ID: 15603955
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of acrylamides as KCNQ2 potassium channel openers.
Wu YJ; He H; Sun LQ; L'Heureux A; Chen J; Dextraze P; Starrett JE; Boissard CG; Gribkoff VK; Natale J; Dworetzky SI
J Med Chem; 2004 May; 47(11):2887-96. PubMed ID: 15139767
[TBL] [Abstract][Full Text] [Related]
5. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
Wickenden AD; Krajewski JL; London B; Wagoner PK; Wilson WA; Clark S; Roeloffs R; McNaughton-Smith G; Rigdon GC
Mol Pharmacol; 2008 Mar; 73(3):977-86. PubMed ID: 18089837
[TBL] [Abstract][Full Text] [Related]
6. (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine.
Wu YJ; Boissard CG; Greco C; Gribkoff VK; Harden DG; He H; L'Heureux A; Kang SH; Kinney GG; Knox RJ; Natale J; Newton AE; Lehtinen-Oboma S; Sinz MW; Sivarao DV; Starrett JE; Sun LQ; Tertyshnikova S; Thompson MW; Weaver D; Wong HS; Zhang L; Dworetzky SI
J Med Chem; 2003 Jul; 46(15):3197-200. PubMed ID: 12852750
[TBL] [Abstract][Full Text] [Related]
7. Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain.
Wu YJ; Conway CM; Sun LQ; Machet F; Chen J; Chen P; He H; Bourin C; Calandra V; Polino JL; Davis CD; Heman K; Gribkoff VK; Boissard CG; Knox RJ; Thompson MW; Fitzpatrick W; Weaver D; Harden DG; Natale J; Dworetzky SI; Starrett JE
Bioorg Med Chem Lett; 2013 Nov; 23(22):6188-91. PubMed ID: 24070783
[TBL] [Abstract][Full Text] [Related]
8. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
Bentzen BH; Schmitt N; Calloe K; Dalby Brown W; Grunnet M; Olesen SP
Neuropharmacology; 2006 Nov; 51(6):1068-77. PubMed ID: 16904708
[TBL] [Abstract][Full Text] [Related]
9. Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor.
Bonaventure P; Nepomuceno D; Mazur C; Lord B; Rudolph DA; Jablonowski JA; Carruthers NI; Lovenberg TW
J Pharmacol Exp Ther; 2004 Mar; 308(3):1130-7. PubMed ID: 14617685
[TBL] [Abstract][Full Text] [Related]
10. In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models.
Roeloffs R; Wickenden AD; Crean C; Werness S; McNaughton-Smith G; Stables J; McNamara JO; Ghodadra N; Rigdon GC
J Pharmacol Exp Ther; 2008 Sep; 326(3):818-28. PubMed ID: 18577704
[TBL] [Abstract][Full Text] [Related]
11. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives.
Koca M; Servi S; Kirilmis C; Ahmedzade M; Kazaz C; Ozbek B; Otük G
Eur J Med Chem; 2005 Dec; 40(12):1351-8. PubMed ID: 16129517
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist.
Porreca F; Vanderah TW; Guo W; Barth M; Dodey P; Peyrou V; Luccarini JM; Junien JL; Pruneau D
J Pharmacol Exp Ther; 2006 Jul; 318(1):195-205. PubMed ID: 16565167
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 2. The synthesis and antimicrobial activity of some novel 1-(1-benzofuran-2-yl)-2-mesitylethanone derivatives.
Kirilmis C; Ahmedzade M; Servi S; Koca M; Kizirgil A; Kazaz C
Eur J Med Chem; 2008 Feb; 43(2):300-8. PubMed ID: 17513022
[TBL] [Abstract][Full Text] [Related]
15. Microwave assisted synthesis of new indophenazine 1,3,5-trisubstruted pyrazoline derivatives of benzofuran and their antimicrobial activity.
Manna K; Agrawal YK
Bioorg Med Chem Lett; 2009 May; 19(10):2688-92. PubMed ID: 19395261
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of in vitro antiviral activity of 2-[3-(substituted phenyl)-4,5-dihydro-1H-5-pyrazolyl]benzofuran-3-yl chloride derivatives.
Shahar Yar M; Mustaqeem Abdullah M; Husain A; Bhakht MA; De Clercq E
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):949-56. PubMed ID: 19555169
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of some 4-(1H-indol-3-yl)-6-phenyl-1,2,3,4-tetrahydropyrimidin-2-ones/thiones as potent anti-inflammatory agents.
Amir M; Javed SA; Kumar H
Acta Pharm; 2008 Dec; 58(4):467-77. PubMed ID: 19103580
[TBL] [Abstract][Full Text] [Related]
18. Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition.
Wu YJ; Davis CD; Dworetzky S; Fitzpatrick WC; Harden D; He H; Knox RJ; Newton AE; Philip T; Polson C; Sivarao DV; Sun LQ; Tertyshnikova S; Weaver D; Yeola S; Zoeckler M; Sinz MW
J Med Chem; 2003 Aug; 46(18):3778-81. PubMed ID: 12930139
[TBL] [Abstract][Full Text] [Related]
19. The synthesis and structure-activity relationships of 3-amino-4-benzylquinolin-2-ones; discovery of novel KCNQ2 channel openers.
Hewawasam P; Chen N; Ding M; Natale JT; Boissard CG; Yeola S; Gribkoff VK; Starrett J; Dworetzky SI
Bioorg Med Chem Lett; 2004 Apr; 14(7):1615-8. PubMed ID: 15026035
[TBL] [Abstract][Full Text] [Related]
20. Focused library development of 2-phenylacrylamides as broad spectrum cytotoxic agents.
Tarleton M; Dyson L; Gilbert J; Sakoff JA; McCluskey A
Bioorg Med Chem; 2013 Jan; 21(1):333-47. PubMed ID: 23176751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
